Glenmede Trust’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67M Buy
4,584
+146
+3% +$54.8K 0.01% 632
2026
Q1
$1.25M Buy
4,438
+75
+2% +$21.8K 0.01% 670
2025
Q4
$1.29M Buy
+4,363
New +$1.31M 0.01% 658

Other funds holding CLS

Glenmede Trust's CLS Position: Q2 2026 in Review

Glenmede Trust increased its Celestica (CLS) stake by 3.3% in Q2 2026, buying an estimated $54.8K and bringing the position to 4,584 shares worth $1.67M. The position accounts for 0.01% of the portfolio, ranked #632.

Glenmede Trust first reported a position in CLS in Q4 2025 and has held it in 3 quarters since. 875 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

  • Glenmede Trust held 4,584 shares of Celestica worth $1.67M as of Q2 2026.
  • Glenmede Trust bought 146 Celestica shares in Q2 2026, an estimated $54.8K.
  • Celestica made up 0.01% of Glenmede Trust's portfolio in Q2 2026, its #632 holding.
  • Glenmede Trust first reported a position in Celestica in Q4 2025 and has held it in 3 quarters since.
  • 875 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.